Skip to main content
Clinical Trials/NCT03739164
NCT03739164Enrolling By InvitationNot Applicable

Complete Robotic Tampa Associating Microwave Liver Ablation With Portal Vein Ligation

Florida Hospital Tampa Bay Division1 site in 1 country10 target enrollmentStarted: July 18, 2018Last updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Status
Enrolling By Invitation
Sponsor
Enrollment
10
Locations
1
Primary Endpoint
Growth of the Future Liver remnant

Study Overview

Brief Summary

This is a study following the outcomes and survival of patients undergoing the TAMLAPS hepatectomy at Florida Hospital Tampa by Dr. Iswanto Sucandy

Study Design

Study Type
Observational
Observational Model
Case Only
Time Perspective
Prospective

Eligibility Criteria

Ages
18 Years to 80 Years (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • Subjects with history of noncompliance.
  • Subjects with physical health, substance abuse, or mental health problems that will limit the subject's ability to meet study requirements

Outcomes

Primary Outcomes

Growth of the Future Liver remnant

Time Frame: 2 weeks

1. Liver growth determined by measuring the kinetic growth rate obtained from pre-operative and post-op stage one CT evaluations of the FLR volume

Secondary Outcomes

No secondary outcomes reported

Investigators

Sponsor
Florida Hospital Tampa Bay Division
Sponsor Class
Other
Responsible Party
Sponsor

Study Sites (1)

Loading locations...

Similar Trials